Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001

Journal of Rheumatology

Volumn 33, Issue 10, 2006, Pages 2060-2063

  Knight, Ann ^a,b   Ekbom, Anders ^b   Brandt, Lena ^b   Askling, Johan ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antineutrophil cytoplasmic antibodies; Incidence; Sweden; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOASSAY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; REGISTER; SWEDEN; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SWEDEN; WEGENER GRANULOMATOSIS;

EID: 33749989988     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Andrews M. Edmunds M. Campbell A, Walls J, Feehally J. Systemic vasculitis in the 1980s - is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond 1990;24:284-8.
2. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87-92.
3. Gonzalez-Gay MA, Garcia-Porrua C, Guerrero J, Rodriguez-Ledo P, Llorca J. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. Arthritis Rheum 2003;49:388-93.
4. Koldingsnes W, Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis Rheum 2000;43:2481-7.
5. Watts RA, Gonzalez-Gay MA, Lane SE, Garcia-Porrua C, Bentham G, Scott DG. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe. Ann Rheum Dis 2001;60:170-2.
6. Carruthers DM, Watts RA, Symmons DP, Scott DG. Wegener's granulomatosis - increased incidence or increased recognition? Br J Rheumatol 1996;35:142-5.
7. Mahr A, Guillevin L, Poissonnet M, Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004;51:92-9.
8. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, et al. No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register. Rheumatology Oxford 2002;41:540-9.
9. Tidman M, Olander R, Svalander C, Daniclsson D. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. J Intern Med 1998;244:133-41.
10. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000;43:414-9.
11. Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL. Stable incidences of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 2005;53:93-9.
12. Savige J, Gillis D, Benson E, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
13. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
14. Patientregistret 1987-1996 Kvalitet och innehåll. Stockholm: Epidemiologist Centrum, Socialstyrelsen; 1998.
15. Lunde AS, Lundeborg S, Lettenstrom GS, Thygesen L, Huebner J. The person-number systems of Sweden, Norway, Denmark, and Israel. Vital Health Sun 2 1980;2:1-59.
16. Knight A, Askling J, Ekbom A. Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer 2002;100:82-5.
17. Knight A, Askling J, Granath F, Sparen P, Ekbom A. Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide. Ann Rheum Dis 2004;63:1307-11.
18. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
19. Watts RA, Lane SE, Bentham G, Scott DG. Epidemiology of systemic vasculitis: a ten year study in the United Kingdom. Arthritis Rheum 2000;43:414-9.
20. Guillevin L, Mahr A, Callard P, et al. Hepatitis B-virus associated polyarteritis nodosa: clinical characteristics, outcome and impact of treatment in 115 patients. Medicine Baltimore 2005;84:313-22.